Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Short term Debt (2022 - 2026)

Cryo Cell International's Short term Debt history spans 5 years, with the latest figure at $1.6 million for Q1 2026.

  • Quarterly results put Short term Debt at $1.6 million for Q1 2026, down 64.99% from a year ago — trailing twelve months through Feb 2026 was $1.6 million (down 64.99% YoY), and the annual figure for FY2025 was $2.3 million, down 34.66%.
  • Short term Debt for Q1 2026 was $1.6 million at Cryo Cell International, down from $2.3 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $6.6 million in Q2 2025 to a low of $1.2 million in Q4 2023.
  • The 5-year median for Short term Debt is $2.3 million (2022), against an average of $2.9 million.
  • The sharpest move saw Short term Debt surged 187.88% in 2024, then crashed 64.99% in 2026.
  • Year by year, Short term Debt stood at $2.3 million in 2022, then plummeted by 46.2% to $1.2 million in 2023, then surged by 187.88% to $3.5 million in 2024, then tumbled by 34.66% to $2.3 million in 2025, then tumbled by 30.43% to $1.6 million in 2026.
  • According to Business Quant data, Short term Debt over the past three periods came in at $1.6 million, $2.3 million, and $3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.